[
  {
    "ts": "2025-11-06T00:30:02+00:00",
    "headline": "AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here?",
    "summary": "AbbVie just increased its dividend by 5.5%, raising the quarterly payout to $1.73 per share starting February 2026, reflecting strong confidence in its long-term growth driven by new drugs like Skyrizi and Rinvoq.",
    "url": "https://www.barchart.com/story/news/35937876/abbvie-just-raised-its-dividend-by-5-5-should-you-buy-abbv-stock-here",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "5c087608-408a-3a7c-908f-890e9eba6a1f",
      "content": {
        "id": "5c087608-408a-3a7c-908f-890e9eba6a1f",
        "contentType": "STORY",
        "title": "AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here?",
        "description": "",
        "summary": "AbbVie just increased its dividend by 5.5%, raising the quarterly payout to $1.73 per share starting February 2026, reflecting strong confidence in its long-term growth driven by new drugs like Skyrizi and Rinvoq.",
        "pubDate": "2025-11-06T00:30:02Z",
        "displayTime": "2025-11-06T00:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/6bfd1299ad5cde0cd67bf828eac1bf36",
          "originalWidth": 1600,
          "originalHeight": 1067,
          "caption": "Dividends by Designer491 via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MxxeLDy7no0CEIMc_GwcWw--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/6bfd1299ad5cde0cd67bf828eac1bf36.cf.webp",
              "width": 1600,
              "height": 1067,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fpTNwfWtnqI68jJHd_tzOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/6bfd1299ad5cde0cd67bf828eac1bf36.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35937876/abbvie-just-raised-its-dividend-by-5-5-should-you-buy-abbv-stock-here",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-just-raised-dividend-5-003002045.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T04:11:45+00:00",
    "headline": "Jim Cramer Says “I Found the AbbVie Call Particularly Jarring”",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the possible change in spending habits of the rich while discussing the stock, as he said: “AbbVie stock is still falling after management talked about slowing medical aesthetic sales. Botox for the face may have finally hit a wall, even […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-found-abbvie-041145260.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ebc2eb7a-f36f-318a-893f-738f0f37e894",
      "content": {
        "id": "ebc2eb7a-f36f-318a-893f-738f0f37e894",
        "contentType": "STORY",
        "title": "Jim Cramer Says “I Found the AbbVie Call Particularly Jarring”",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the possible change in spending habits of the rich while discussing the stock, as he said: “AbbVie stock is still falling after management talked about slowing medical aesthetic sales. Botox for the face may have finally hit a wall, even […]",
        "pubDate": "2025-11-06T04:11:45Z",
        "displayTime": "2025-11-06T04:11:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E2lv2kKRF2jXt8F.V84xVw--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BN9PfJYu5RffW4DiInJR2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7b1d6a1350c79cef49b9cb2889204dd6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-found-abbvie-041145260.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-found-abbvie-041145260.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T11:30:30+00:00",
    "headline": "Lower interest rates could boost these stocks & sectors",
    "summary": "Miramar Capital co-founder and senior portfolio manager, Max Wasserman, joins Morning Brief host Julie Hyman to discuss portfolio diversification and which stocks and sectors are poised to benefit as interest rates continue to come down. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finance.yahoo.com/video/lower-interest-rates-could-boost-113030741.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "09143a2c-6017-3fe9-b40a-939c5c0611c5",
      "content": {
        "id": "09143a2c-6017-3fe9-b40a-939c5c0611c5",
        "contentType": "VIDEO",
        "title": "Lower interest rates could boost these stocks & sectors",
        "description": "<p>Miramar Capital co-founder and senior portfolio manager, Max Wasserman, joins Morning Brief host <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> to discuss portfolio diversification and which stocks and sectors are poised to benefit as interest rates continue to come down.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Miramar Capital co-founder and senior portfolio manager, Max Wasserman, joins Morning Brief host Julie Hyman to discuss portfolio diversification and which stocks and sectors are poised to benefit as interest rates continue to come down. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
        "pubDate": "2025-11-06T11:30:30Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ee475c60-b9a2-11f0-b5f7-bd709ac6e589",
          "originalWidth": 5700,
          "originalHeight": 3209,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r4WXnmSY1X2d3smC1MH3VA--~B/aD0zMjA5O3c9NTcwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ee475c60-b9a2-11f0-b5f7-bd709ac6e589.cf.webp",
              "width": 5700,
              "height": 3209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R872H9Y1YLNcU_FIqI5drw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ee475c60-b9a2-11f0-b5f7-bd709ac6e589.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/lower-interest-rates-could-boost-113030741.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/lower-interest-rates-could-boost-113030741.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "XLV"
            },
            {
              "symbol": "HD"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "WM"
            },
            {
              "symbol": "MCD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T12:35:58+00:00",
    "headline": "Former blockbuster Linzess grows label with paediatric IBS-C approval",
    "summary": "Linzess becomes the first FDA-approved treatment for IBS-C in paediatric patients.",
    "url": "https://www.pharmaceutical-technology.com/news/former-blockbuster-linzess-grows-label-with-paediatric-ibs-c-approval/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "7aa45030-f8c8-32f0-a058-e179de616c63",
      "content": {
        "id": "7aa45030-f8c8-32f0-a058-e179de616c63",
        "contentType": "STORY",
        "title": "Former blockbuster Linzess grows label with paediatric IBS-C approval",
        "description": "",
        "summary": "Linzess becomes the first FDA-approved treatment for IBS-C in paediatric patients.",
        "pubDate": "2025-11-06T12:35:58Z",
        "displayTime": "2025-11-06T12:35:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/6f20e56b9d42d37f24e7ff4e4183373d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/as_oEHIOV8urKOlpVTrHlQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/6f20e56b9d42d37f24e7ff4e4183373d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GWXXVvkZu_VQ3JUAcRJdzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/6f20e56b9d42d37f24e7ff4e4183373d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/former-blockbuster-linzess-grows-label-with-paediatric-ibs-c-approval/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/former-blockbuster-linzess-grows-label-123558580.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IRWD"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-06T12:05:00+00:00",
    "headline": "REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights",
    "summary": "REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational highlights for the third quarter ended September 30, 2025.",
    "url": "https://finance.yahoo.com/news/regenxbio-reports-third-quarter-2025-120500174.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f3e8c759-6a51-3413-9aa8-af96476a5f00",
      "content": {
        "id": "f3e8c759-6a51-3413-9aa8-af96476a5f00",
        "contentType": "STORY",
        "title": "REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights",
        "description": "",
        "summary": "REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational highlights for the third quarter ended September 30, 2025.",
        "pubDate": "2025-11-06T12:05:00Z",
        "displayTime": "2025-11-06T12:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1f5146fa14fd37e9771ad82d6ca9dbf2",
          "originalWidth": 400,
          "originalHeight": 69,
          "caption": "(PRNewsfoto/REGENXBIO Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WpqvsnNQrohvrEBhI_5CNA--~B/aD02OTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/1f5146fa14fd37e9771ad82d6ca9dbf2.cf.webp",
              "width": 400,
              "height": 69,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R8n54WM.USed7zeIAMSCQA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1f5146fa14fd37e9771ad82d6ca9dbf2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regenxbio-reports-third-quarter-2025-120500174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regenxbio-reports-third-quarter-2025-120500174.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RGNX"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]